Table 2.

Serum TIMP-1 and MMP-9 levels at day 1, 4 and 8 of severe MMCAI in 30-day surviving and non-surviving patients

Parameters Median and percentiles 25th -75th	Survivors	Nonsurvivors	P
Day 1	(n = 34)	(n = 34)
TIMP-1 (ng/mL) - median (p 25–75)	206 (173–262)	375 (248–468)	< 0.001
MMP-9 (ng/mL) - median (p 25–75)	839 (719–1192)	708 (396–949)	0.03
Day 4	(n = 34)	(n = 18)
TIMP-1 (ng/mL) - median (p 25–75)	208 (193–247)	350 (213–461)	< 0.001
MMP-9 (ng/mL) - median (p 25–75)	596 (408–792)	414 (183–884)	0.13
Day 8	(n = 34)	(n = 12)
TIMP-1 (ng/mL) - median (p 25–75)	234 (213–262)	370 (211–451)	0.03
MMP-9 (ng/mL) - median (p 25–75)	370 (295–721)	361 (211–459)	0.61